Navigation Links
Coroner Says Sativex Is Responsible For Death Of Patient

A marijuana plant based experimental medicine known as Sativex, is responsible for the death of Rene Anderson, a diabetic pensioner, a coroner has ruled in the UK. The drug was prescribed to Mrs. Anderson to ease the numbness and pain in her limbs due to diabetes.

// The medicine is reported to have resulted disturbed behavior, and the patient was later taken to hospital in an intoxicated and confused state. Here her condition continued to deteriorate, resulting in her death due to kidney failure five months later at the Northern General Hospital. The coroner admitted that the reason for the continued deterioration of Mrs. Anderson’s health even after she was taken off the drug was unknown.

Sativex is manufactured by GW Pharmaceuticals to relieve severe pain. The company sources insist that over 2,000 people have been administered with the drug during its development, and there were no deaths as a result of this. The project is funded by the Diabetes UK, and it is licensed in Canada. The family of Mrs. Anderson insists upon a ban on the further trials of the drug, stating that the patient has been used as a guinea pig for an unsafe drug.
'"/>




Page: 1

Related medicine news :

1. Allergic Individuals Should Carry Two Doses Of EpiPen Says Quebec Coroner
2. PET Scan find the Area of Brain Responsible for Anorexia Nervosa
3. Arsenic May Have Been Responsible For The Madness Of King George III Of England
4. Gene That Might Be Responsible For Aging
5. Enzyme Responsible For Congenital Blindness
6. New Virus Held Responsible For Respiratory Infection In Children
7. Researchers Identify Sipa 1 Gene, Responsible For Cancer Metastasis
8. Nurse Held Responsible For Insulin Overdose
9. Alcohol Is Responsible For 60 Different Diseases
10. Scientists Identify Gene Responsible For Depression
11. Genes That Were Responsible For The Cause Of Blindness Identified
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... The ... the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. ... safety. Only a few hospitals and facilities have earned this distinction. This is ...
(Date:12/8/2016)... JENNERSVILLE, Pa. (PRWEB) , ... December 08, 2016 ... ... Penn Medicine Southern Chester County, a Property owned by an affiliate of Seavest, ... 72,000 square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it had joined the Pharmaceutical ... a non-profit organization to unite pharmaceutical and healthcare companies that share a vision ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Dec 9, 2016 Research and Markets has announced ... Business Report" report to their offering. ... The report also analyses the market by the following ... comprehensive analytics for the US, Canada , ... , Latin America , and Rest of World. ...
(Date:12/9/2016)... Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... of Physiocrine-based therapeutics to address severe, rare diseases, today announced that ... BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay Hotel ... 14, 2016, at 4:20 p.m. ET. About aTyr ... aTyr ...
(Date:12/9/2016)... DIEGO , Dec. 9, 2016  Forge ... Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: ... targeting ,LpxC, for the treatment of bacterial infections ... has been recognized as an attractive antibacterial target ... a lack of suitable chemical starting points has ...
Breaking Medicine Technology: